| scholarly article | Q13442814 |
| P2093 | author name string | Rui Wang | |
| Bing Zhou | |||
| Arul M Chinnaiyan | |||
| Xuhong Cao | |||
| Yuping Wang | |||
| Shaomeng Wang | |||
| Rohit Malik | |||
| Andrzej A Dlugosz | |||
| Jae Eun Choi | |||
| Doris Mangelberger | |||
| Fengyun Su | |||
| Monique E Verhaegen | |||
| Paul W Harms | |||
| Xiaojun Jing | |||
| Ingrid J Apel | |||
| Marcin Cieślik | |||
| Jean Tien | |||
| Jonathan Gurkan | |||
| Kristin Juckette | |||
| Mishaal Yazdani | |||
| Sahr Yazdani | |||
| P2860 | cites work | Selective inhibition of BET bromodomains | Q24301009 |
| Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma | Q27853225 | ||
| PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. | Q27853379 | ||
| edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | Q27860819 | ||
| BET bromodomain inhibition as a therapeutic strategy to target c-Myc | Q28247024 | ||
| limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
| voom: Precision weights unlock linear model analysis tools for RNA-seq read counts | Q33741687 | ||
| A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331) | Q34088836 | ||
| Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system | Q34208807 | ||
| Merkel cell carcinoma dependence on bcl-2 family members for survival. | Q34273863 | ||
| Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer | Q34416771 | ||
| Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice. | Q34443490 | ||
| Separate-channel analysis of two-channel microarrays: recovering inter-spot information | Q34739043 | ||
| Embryonic maturation of epidermal Merkel cells is controlled by a redundant transcription factor network | Q34985761 | ||
| Unipotent, Atoh1+ progenitors maintain the Merkel cell population in embryonic and adult mice | Q35042887 | ||
| BET protein inhibitor JQ1 attenuates Myc-amplified MCC tumor growth in vivo | Q35066871 | ||
| BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells | Q35574955 | ||
| Ectopic Atoh1 expression drives Merkel cell production in embryonic, postnatal and adult mouse epidermis | Q35878136 | ||
| Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins | Q36436791 | ||
| Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis | Q36684979 | ||
| PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer | Q37065079 | ||
| Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer | Q37362732 | ||
| Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial | Q38378516 | ||
| Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression. | Q38710711 | ||
| Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System | Q38838916 | ||
| Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression | Q38845398 | ||
| Merkel Cell Polyomavirus Small T Antigen Initiates Merkel Cell Carcinoma-like Tumor Development in Mice | Q40198756 | ||
| Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer. | Q42775768 | ||
| Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. | Q45947378 | ||
| BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment. | Q50547887 | ||
| Clinical remission of Merkel cell carcinoma after treatment with imatinib | Q85766984 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Merkel cell carcinoma | Q1711744 |
| P304 | page(s) | 322-330 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | Neoplasia | Q2962042 |
| P1476 | title | Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma | |
| P478 | volume | 21 |
| Q93016452 | Targeting BET Proteins With a PROTAC Molecule Elicits Potent Anticancer Activity in HCC Cells | cites work | P2860 |
Search more.